LuzElenaCastellanosMD

PubMed

• Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.
  Gouda, M., Iorgulescu, J., Shen, T., Wu, J., Subbiah, V., Dadu, R., Patel, K., Sherman, S., Cabanillas, M., Hu, M., Castellanos, L., Amini, B., Meric-Bernstam, F.> ;NPJ Precision Oncology. 2024 Mar 4
• 9 citations
  Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification
  Luz E. Castellanos, Timothy R. Smith, Edward R. Laws, J. Bryan Iorgulescu> ;Pituitary. 2021 Sep 27
• 27 citations
  Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
  Luz E. Castellanos, Courtney A. Balliro, Jordan Sherwood, Rabab Z. Jafri, Mallory A. Hillard, Evelyn Greaux, Rajendranath Selagamsetty, Hui Zheng, El-Khatib Firas H, E...> ;Diabetes Care. 2021 Apr 27
• 6 citations
  The epidemiology and management patterns of pediatric pituitary tumors in the United States
  Luz E. Castellanos, Madhusmita Misra, Timothy R. Smith, Edward R. Laws, J. Bryan Iorgulescu> ;Pituitary. 2021 Jan 12
• 19 citations
  Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus
  Luz E. Castellanos, Marwa Tuffaha, Dorit Koren, Lynne L. Levitsky> ;Paediatric Drugs. 2020 May 25
• Join now to see all